|Bid||3,851.00 x 0|
|Ask||3,852.00 x 0|
|Day's Range||3,841.00 - 3,871.00|
|52 Week Range||2,505.00 - 4,099.00|
|Beta (5Y Monthly)||0.40|
|PE Ratio (TTM)||48.67|
|Earnings Date||Jul 21, 2020|
|Forward Dividend & Yield||62.00 (1.60%)|
|Ex-Dividend Date||Mar 27, 2020|
|1y Target Est||2,253.37|
Moody's Investors Service, ("Moody's") has today assigned a Baa1 rating to the proposed CHF150 million Swiss Domestic issuance of Givaudan SA (Givaudan) and it has affirmed the Baa1 LT Issuer Rating. A full list of affected ratings can be found at the end of this press release.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Innophos Holdings, Inc. (New) and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.
Givaudan, the global leader in the creation of fragrances and flavours, said its sales rose 3.1% on a like-for-like basis in the July-September quarter, supported by strong demand for household, health and personal care products during the COVID-19 pandemic.